Saccharomyces boulardii Alleviates Ovalbumin‐Induced Pyroptosis Through Cyba and IL‐17 Signaling Pathway
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Zhifeng Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Pyroptosis, Interleukin-17, Probiotics, Saccharomyces boulardii. Die Arbeit nennt 89 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Scientific Foundation of Hunan Province, Science and Technology Innovation Project of Hunan Province.
Abstract (Originalsprache)
Saccharomyces boulardii ( S. boulardii ), a beneficial yeast probiotic, is effective in treating asthma in children. This study aimed to examine the effects of S. boulardii on Ovalbumin (OVA)‐induced pyroptosis in human bronchial epithelial cells. An OVA‐induced asthma mouse model was used with S. boulardii as an intervention. S. boulardii alleviated OVA‐induced lung tissue pyroptosis and intestinal tissue damage in asthmatic mice. The mRNA sequencing analysis revealed differentially expressed genes, including elevated Cyba levels in the intestinal tissues of the OVA group. However, S. boulardii reduced Cyba levels. Gene Set Enrichment analysis showed the involvement of IL‐17 signaling pathway. In vivo experiments showed that S. boulardii inhibited IL‐17 signaling pathway in the intestinal and lung tissues. In vitro experiments revealed that IL‐17 regulation of ROS production, promoting BEAS‐2B cell pyroptosis, required the involvement of Cyba. Moreover, Cyba knockdown inhibited activation of NLRC4 and NLRP3 inflammasomes induced by IL‐17 in vivo. This study revealed for the first time the important role of Cyba and IL‐17 pathways in asthma pathology and demonstrated that S. boulardii exerted its therapeutic effects by modulating these pathways. These findings provided a basis for developing nutrition interventions targeting gut microbiota and immune health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Emergency, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Subo Gong
Förderung
- National Natural Science Foundation of China
- Natural Scientific Foundation of Hunan Province
- Science and Technology Innovation Project of Hunan Province
- Popular Science Project of Hunan Province
Zitieren
APA
Chen, Z., Hu, L., Yang, Y., Wang, Y., Li, Y., Su, J., Wang, G., & Gong, S. (2025). Saccharomyces boulardii Alleviates Ovalbumin‐Induced Pyroptosis Through Cyba and IL‐17 Signaling Pathway. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70194
Vancouver
Chen Z, Hu L, Yang Y, Wang Y, Li Y, Su J, et al. Saccharomyces boulardii Alleviates Ovalbumin‐Induced Pyroptosis Through Cyba and IL‐17 Signaling Pathway. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70194
BibTeX
@article{Chen2025,
author = {Chen, Zhifeng and Hu, Lang and Yang, Yue and Wang, Yina and Li, Yayong and Su, Jing and Wang, Guyi and Gong, Subo},
title = {Saccharomyces boulardii Alleviates Ovalbumin‐Induced Pyroptosis Through Cyba and IL‐17 Signaling Pathway},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70194}
}
EUVIMED